Basic Information
Altimmune is a clinical-stage biopharmaceutical company focused on developing treatments for obesity and liver diseases as well as intranasal vaccines. Our pipeline includes next-generation peptide therapies for obesity, NASH (ALT-801), and chronic hepatitis B (HepTcell™); proprietary intranasal vaccines; and an immunomodulatory therapy for COVID-19 (T-COVID™).
Altimmune, Inc.
Maryland,United States of America
15~50 people
January 01, 1997
arr@lifesciadvisors.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios